Zobrazeno 1 - 10
of 21
pro vyhledávání: '"M Firnhaber"'
Autor:
Jonathon M. Firnhaber
Publikováno v:
Primary Care: Clinics in Office Practice. 48:645-654
Pulmonary function testing (PFT) is an important component of the evaluation, monitoring, and management of patients with suspected or established lung disease. Spirometry is easily accomplished in the primary care office setting; determination of lu
Autor:
Jonathon M, Firnhaber, C S, Powell
Publikováno v:
American family physician. 105(1)
Atherosclerotic vascular disease is a leading cause of death worldwide. Atherosclerotic stenosis of the internal carotid or intracranial arteries causes up to 15% of strokes. Peripheral artery disease affects up to one in five people in the United St
Publikováno v:
Primary care. 48(4)
Insertion of urinary catheters (most often Foley catheters) can be performed in outpatient settings to manage acute urinary obstruction without referral to emergency services, as well as to obtain urine samples in patients not able to provide a clean
Autor:
Jonathon M. Firnhaber, J. Lane Wilson
Publikováno v:
Primary care. 48(4)
Autor:
Jonathon M, Firnhaber
Publikováno v:
American family physician. 102(6)
Keratinocyte carcinoma, traditionally referred to as nonmelanoma skin cancer, includes basal cell and cutaneous squamous cell carcinoma and is the most common skin cancer malignancy found in humans. The U.S. Preventive Services Task Force recommends
Autor:
J. Lane Wilson, Jonathon M. Firnhaber
Publikováno v:
Primary Care: Clinics in Office Practice. 48:i
Autor:
Jonathon M, Firnhaber, C S, Powell
Publikováno v:
American family physician. 99(6)
Lower extremity peripheral artery disease (PAD) affects 12% to 20% of Americans 60 years and older. The most significant risk factors for PAD are hyperlipidemia, hypertension, diabetes mellitus, chronic kidney disease, and smoking; the presence of th
Autor:
Jonathon M, Firnhaber
Publikováno v:
The Journal of family practice. 67(9)
CVD risk prediction tools have largely been used to determine the advisability of statin therapy. They might be better used to counsel patients about across-the-board risk factor modification.
Autor:
Jonathon M, Firnhaber
Publikováno v:
The Journal of family practice. 67(6)
Considering a non-statin intervention? Choose one that upregulates LDL-C-receptor expression. Adding a PCSK9 inhibitor to statin therapy is effective, but expensive.
Publikováno v:
Nutrition Today. 51:18-24
For more than 20 years, older women were encouraged by their healthcare providers to supplement their diets with calcium and vitamin D3 to reduce their risk of hip and other fractures. In recent years, evidence has been mounting that calcium suppleme